Showing 1821-1830 of 2657 results for "".
- Ophthalmic World Leaders (OWL) Names First MD President and Other Leadership Changes for 2026https://modernod.com/news/ophthalmic-world-leaders-owl-names-first-md-president-and-other-leadership-changes-for-2026/2484293/Ophthalmic World Leaders (OWL) announces the appointment of Renee Bovelle, MD, as its new President. OWL also welcomes three new members to its Board of Directors: Kevin M. Douglas, MD (Medical Director, Eye Care – Retina, AbbVie), Maáza Martin (S
- Smartlens Secures $5.2 Million to Advance FDA Clearance and Commercial Launch of miLenshttps://modernod.com/news/smartlens-secures-52-million-to-advance-fda-clearance-and-commercial-launch-of-milens/2484291/Smartlens announced the closing of an oversubscribed $5.2 million bridge financing round to accelerate the company’s FDA clearance process and support preparations for an expedited U.S. market launch of its flagship product, miLens, f
- Nanoscope Announces 3-Year Vision Improvements from REMAIN Study of MCO-010 in RPhttps://modernod.com/news/nanoscope-announces-3-year-vision-improvements-from-remain-study-of-mco-010-in-retinitis-pigmentosa/2484207/Nanoscope Therapeutics announced 3-year follow-up data from the REMAIN study, the long-term extension of its pivotal phase 2b/3 RESTORE trial evaluating MCO-010, the company’s proprietary optogenetic therapy for retinitis pigmentosa (RP).
- Bausch + Lomb's Surgical Planning Software, Eyetelligence, Now Fully Commercially Available in UShttps://modernod.com/news/bausch-lombs-surgical-planning-software-eyetelligence-now-fully-commercially-available-in-us/2484204/Bausch + Lomb announced that its surgical planning software, Eyetelligence, is now available to all US ophthalmologists. Eyetelligence is designed to streamline a clinic’s operations and bring connectivity into the OR. According to B+L, the software helps surgeons make quick
- Heru Surpasses One Million Eyes Tested on Its AI-Powered Wearable Vision Diagnostics Platformhttps://modernod.com/news/heru-surpasses-one-million-eyes-tested-on-its-ai-powered-wearable-vision-diagnostics-platform/2484185/Heru announced that it has surpassed 1 million eyes tested on its wearable platform. Founded out of the Bascom Palmer Eye Institute, Heru's AI-driven platform replaces multiple pieces of traditional diagnostic equ
- Avisi Technologies Receives FDA Approval to Study Novel Approach to Glaucoma Treatmenthttps://modernod.com/news/avisi-technologies-receives-fda-approval-to-study-novel-approach-to-glaucoma-treatment/2484182/Avisi Technologies announced that the FDA has approved an investigational device exemption (IDE) for its glaucoma treatment device, VisiPlate. This milestone paves the way for the company’s SAPPHIRE clinical trial, which will evaluate the device in patie
- SpyGlass Pharma Announces Promising 24-Month Interim Results from First-in-Human Trial of BIM-IOL Systemhttps://modernod.com/news/spyglass-pharma-announces-promising-24-month-interim-results-from-first-in-human-trial-of-bim-iol-system/2484179/SpyGlass Pharma announced interim 24-month data from its first-in-human clinical trial evaluating the Bimatoprost Drug Pad-IOL System (BIM-IOL System). This technology integrates proprietary non-bioerodible drug pads with SpyGlass Pharma’s IOL, designed
- FDA Clears Complement Therapeutics’ IND Application for CTx001 Gene Therapy in GAhttps://modernod.com/news/fda-clears-complement-therapeutics-ind-application-for-ctx001-gene-therapy-in-ga/2484178/Complement Therapeutics has announced that the FDA has cleared its investigational new drug (IND) application for CTx001, the company’s lead gene therapy candidate. The clearance paves the way for the initiation of Opti-GAIN, a phase 1/2 clinic
- BVI Receives FDA Approval for Finevision HP Trifocal IOLhttps://modernod.com/news/bvi-receives-fda-approval-for-finevision-hp-trifocal-iol/2484174/BVI announced that the FDA has approved its Finevision HP trifocal IOL. According to BVI, Finevision HP was the world’s first trifocal IOL, with more than 15 years of clinical success a
- Rayner Secures FDA Approval for RayOne EMV Toric IOLhttps://modernod.com/news/rayner-secures-fda-approval-for-rayone-emv-toric-iol/2484172/The FDA has approved Rayner's RayOne EMV Toric IOL following the completion of a pivotal investigational device exemption (IDE) study. According to Rayner, the RayOne EMV Toric lens has been enginee